![Hoe eenvoudige semantiek onze AI-citaties met 642% verhoogde [Nieuwe resultaten]](https://www.pharmamarketeer.nl/wp-content/uploads/2026/01/719-370x300.jpg)
The Food and Drug Administration (FDA) has granted Orphan Drug designation to ARO-ANG3 (Arrowhead Pharmaceuticals) for the treatment of homozygous familial hypercholesterolemia. ARO-ANG3 is a subcutaneously administered...
FDA approves MSD’s combo therapy Recarbrio for urinary tract and intra-abdominal infections
MSD has announced the approval from the FDA of its combination therapy Recarbrio (imipenem, cilastatin and relebactam) in the treatment of adult patients with complicated urinary tract infections (cUTI) and complicated...
Indicatie liraglutide uitgebreid
De Committee for Medicinal Products for Human Use (CHMP) heeft geadviseerd de indicatie van liraglutide (Victoza) uit te breiden, zodat deze ook geïndiceerd is voor de behandeling van diabetes mellitus type 2 bij...
Make Your Content Marketing Strategy Useful – Do It in Visuals
Do execs’ eyes gloss over when you present the brand’s content marketing strategy? Is the text-based document collecting dust on your team’s desks? Ensure that your content marketing strategy is understood – and used –...
32 (Surprising?) Ways to Define a Home Run in Content Marketing
You know what a home run is in baseball – it gets the biggest crowd reaction. But what’s its equivalent in content marketing? We asked Content Marketing World 2019 speakers to define it. Their answers may surprise you...
Recursion raises $121m for AI-led drug discovery
Funds will fuel in house pipeline and tech
AI-enabled device detects if targeted chemotherapy is working
A new portable device that utilizes artificial intelligence (AI) and biosensors can rapidly detect if cancer cells thrive after chemotherapy treatment.
RNAi Therapy Gets Breakthrough Status for Primary Hyperoxaluria Type 1
The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to DCR-PHXC (Dicerna Pharmaceuticals) for the treatment of patients with primary hyperoxaluria type 1 (caused by a mutation in the AGXT...
Bayer’s Gadavist becomes first FDA-approved drug for MRI in coronary artery disease patients
The FDA has awarded approval to Bayer’s Gadavist (gadobutrol) injection, the company confirmed.
read more
Crizanlizumab Granted Priority Review for Sickle Cell Pain Crises Prevention
The Food and Drug Administration (FDA) has accepted for Priority Review the Biologics License Application (BLA) for crizanlizumab (SEG101; Novartis) for the prevention of vaso-occlusive crises in patients with sickle...
Hoe heb je effect met social media?
In haar derde boek ‘Super Social’ legt socialmedia-trainer Elja Daae uit hoe je in deze tijd effect hebt met de inzet van sociale media. Nu algoritmes continu veranderen, wordt het steeds moeilijker om je...
Goede content heeft een originele invalshoek
Content die weinig traffic genereert hoeft niet meteen te worden afgeschreven. Met een aantal aanpassingen kun je content die weinig aandacht oplevert nieuw leven in blazen.
Wetenschap vs praktijk: wat is de meest succesvolle (marketing)strategie?
We lezen, horen en voelen het allemaal. In de huidige dynamische markt, waarin ontwikkelingen elkaar razendsnel opvolgen, wordt er als organisatie, maar ook als marketeer steeds meer van je verwacht.
Content Is NOT the Same as Content Marketing
An e-book is not content marketing. Social media posts are not content marketing. Does your brand market with content? Or do you do content marketing? Explore the difference and learn the eight steps to really do...
Biohaven’s CGPR antagonist migraine treatment beats placebo in Phase 3 trial
Connecticut-based firm Biohaven has said its migraine drug rimegepant showed superiority over placebo in a Phase 3 clinical trial. The calcitonin gene-related peptide (CGRP) receptor antagonist was successful in...
GSK’s ovarian cancer treatment meets main goal in late-stage study
GlaxoSmithKline said on Monday a late-stage study testing its initial maintenance therapy, Zejula, in patients with ovarian cancer who have undergone platinum-based chemotherapy showed positive results.
Rush University Medical Center offers new FDA-approved treatment for brain aneurysms
Rush University Medical Center is offering a newly FDA-approved treatment for brain aneurysms that is safer for patients and has a shorter recovery period than other treatments.
AstraZeneca’s Imfinzi gets orphan drug designation from FDA
AstraZeneca’s cancer immunotherapy Imfinzi has been granted orphan drug status as a treatment for small cell lung cancer (SCLC). The FDA has granted Imfinzi (Durvalumab) an Orphan Drug Designation (ODD) as a treatment...
